Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 4.000
+0.140 (3.63%)
Mar 23, 2026, 1:59 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 959.64 million as of March 23, 2026. Its market cap has increased by 149.19% in one year.
Market Cap
959.64M
Enterprise Value
677.82M
Revenue
316.70M
Ranking
n/a
PE Ratio
6.54
Stock Price
4.00
Market Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 959.64M, an increase of 696.03%. That is a compound annual growth rate of 20.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 959.64M | -7.77% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 2.08B |
| Egetis Therapeutics AB | 1.97B |
| Diamyd Medical AB | 1.87B |
| BioInvent International AB | 1.43B |
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |
| Genovis AB (publ.) | 1.07B |
| SynAct Pharma AB | 945.31M |